https://www.sciencedaily.com/news/health_medicine/brain_tumor/ What are the risks, symptoms and treatment options for brain tumors and other cancers? Read current medical research and news articles on brain tumor surgery and related information. en-us Mon, 13 Apr 2026 10:43:17 EDT Mon, 13 Apr 2026 10:43:17 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/brain_tumor/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260405003933.htm Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can actually help tumors grow by sending signals that strengthen cancer cells. When researchers blocked this communication, tumor growth slowed dramatically in lab models. Sun, 05 Apr 2026 19:48:12 EDT https://www.sciencedaily.com/releases/2026/04/260405003933.htm https://www.sciencedaily.com/releases/2026/02/260216044003.htm Researchers have built a realistic human mini spinal cord in the lab and used it to simulate traumatic injury. The model reproduced key damage seen in real spinal cord injuries, including inflammation and scar formation. After treatment with fast moving “dancing molecules,” nerve fibers began growing again and scar tissue shrank. The results suggest the therapy could eventually help repair spinal cord damage. Mon, 16 Feb 2026 07:41:25 EST https://www.sciencedaily.com/releases/2026/02/260216044003.htm https://www.sciencedaily.com/releases/2026/02/260212234218.htm Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that special support cells called astrocytes—located far from the actual injury—spring into action after damage. These “lesion-remote astrocytes” send out a protein signal, CCN1, that reprograms immune cells to efficiently clean up fatty nerve debris. Fri, 13 Feb 2026 08:47:43 EST https://www.sciencedaily.com/releases/2026/02/260212234218.htm https://www.sciencedaily.com/releases/2026/01/260128075350.htm Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor can be seen. IDH-mutant glioma, long treated by removing visible tumor tissue, actually starts when normal-looking brain cells quietly acquire a cancer-linked mutation and spread through the brain’s cortex. Using advanced genetic mapping and animal models, researchers traced the cancer’s true origin to glial progenitor cells that appear healthy at first. Wed, 28 Jan 2026 07:53:50 EST https://www.sciencedaily.com/releases/2026/01/260128075350.htm https://www.sciencedaily.com/releases/2025/11/251122044329.htm A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with drugs that boost T-cell activity, the treatment eliminated tumors in mice and built long-lasting immunity. The results suggest a powerful new direction for brain cancer immunotherapy. Sat, 22 Nov 2025 12:24:13 EST https://www.sciencedaily.com/releases/2025/11/251122044329.htm https://www.sciencedaily.com/releases/2025/10/251020092844.htm Neck size is proving to be a powerful indicator of hidden health risks. Larger neck circumferences are associated with cardiovascular disease, diabetes, and sleep apnea, even among those with normal weight. Fat stored in the upper body affects vital metabolic processes, increasing strain on the heart and blood vessels. A simple tape-measure check might reveal more about your health than you think. Mon, 20 Oct 2025 09:28:44 EDT https://www.sciencedaily.com/releases/2025/10/251020092844.htm https://www.sciencedaily.com/releases/2025/10/251013040337.htm Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity. This breakthrough could lead to earlier, less invasive treatments and significantly improve survival. A large NIH trial is underway to confirm the results. Mon, 13 Oct 2025 23:55:21 EDT https://www.sciencedaily.com/releases/2025/10/251013040337.htm https://www.sciencedaily.com/releases/2025/10/251005085618.htm A new study shows glioblastoma isn’t confined to the brain—it erodes the skull and hijacks the immune system within skull marrow. The cancer opens channels that let inflammatory cells enter the brain, fueling its deadly progression. Even drugs meant to protect bones can make things worse, highlighting the need for therapies that target both brain and bone. The discovery reframes glioblastoma as a whole-body disease, not just a brain disorder. Sun, 05 Oct 2025 08:56:18 EDT https://www.sciencedaily.com/releases/2025/10/251005085618.htm https://www.sciencedaily.com/releases/2025/09/250916221917.htm Rogue DNA rings known as ecDNA may hold the key to cracking glioblastoma’s deadly resilience. Emerging before tumors even form, they could offer scientists a crucial early-warning system and a chance to intervene before the disease becomes untreatable. Wed, 17 Sep 2025 21:33:46 EDT https://www.sciencedaily.com/releases/2025/09/250916221917.htm https://www.sciencedaily.com/releases/2025/08/250826005226.htm University of Minnesota researchers developed a 3D-printed scaffold that directs stem cells to grow into functioning nerve cells, successfully restoring movement in rats with severed spinal cords. This promising technique could transform future treatment for spinal cord injuries. Tue, 26 Aug 2025 00:52:26 EDT https://www.sciencedaily.com/releases/2025/08/250826005226.htm https://www.sciencedaily.com/releases/2025/07/250701234744.htm Locked-down Hungarians who gained or lost pets saw almost no lasting shift in mood or loneliness, and new dog owners actually felt less calm and satisfied over time—hinting that the storied “pet effect” may be more myth than mental-health remedy even in extreme isolation. Wed, 02 Jul 2025 05:57:47 EDT https://www.sciencedaily.com/releases/2025/07/250701234744.htm https://www.sciencedaily.com/releases/2025/06/250609060137.htm A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which deliver electric waves into tumors, with immunotherapy and chemotherapy, researchers saw a major boost in survival. Mon, 09 Jun 2025 06:01:37 EDT https://www.sciencedaily.com/releases/2025/06/250609060137.htm https://www.sciencedaily.com/releases/2025/05/250529124400.htm A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer. Thu, 29 May 2025 12:44:00 EDT https://www.sciencedaily.com/releases/2025/05/250529124400.htm https://www.sciencedaily.com/releases/2025/05/250521124115.htm Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are a significant step toward future precise gene therapy to the brain that could safely control errant brain activity with high precision. In contrast, current therapies for brain disorders mostly treat only symptoms. Wed, 21 May 2025 12:41:15 EDT https://www.sciencedaily.com/releases/2025/05/250521124115.htm https://www.sciencedaily.com/releases/2025/05/250521124108.htm Researchers demonstrated unprecedented rates of recovery for spinal cord injuries. Individuals with incomplete spinal cord injury safely received a combination of stimulation of a nerve in the neck with progressive, individualized rehabilitation. This approach, called closed-loop vagus nerve stimulation (CLV), produced meaningful improvements in arm and hand function in these individuals. Wed, 21 May 2025 12:41:08 EDT https://www.sciencedaily.com/releases/2025/05/250521124108.htm https://www.sciencedaily.com/releases/2025/05/250520224245.htm Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team utilized the new approach during 50 brain tumor surgeries to deliver rapid, intraoperative diagnoses. This approach has achieved a 100% success rate, providing diagnostic results in under two hours from surgery and detailed tumor classifications within minutes of sequencing. Tue, 20 May 2025 22:42:45 EDT https://www.sciencedaily.com/releases/2025/05/250520224245.htm https://www.sciencedaily.com/releases/2025/05/250520121154.htm Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for diagnosing HPV-associated head and neck cancers, outperforming standard of care methods. HPV causes about 70% of oropharyngeal cancers in the U.S., which are increasing in incidence faster than other head and neck cancers. Tue, 20 May 2025 12:11:54 EDT https://www.sciencedaily.com/releases/2025/05/250520121154.htm https://www.sciencedaily.com/releases/2025/05/250508161135.htm Brain metastases often occur as a result of advanced cancer and, despite medical innovations, are still associated with a poor prognosis. Now, an international expert committee has taken an important step towards improving diagnostics and therapy monitoring. A special imaging procedure, amino acid PET, can not only improve patient care, but also advance research into the development of new treatment approaches. Thu, 08 May 2025 16:11:35 EDT https://www.sciencedaily.com/releases/2025/05/250508161135.htm https://www.sciencedaily.com/releases/2025/04/250424120856.htm Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy. Thu, 24 Apr 2025 12:08:56 EDT https://www.sciencedaily.com/releases/2025/04/250424120856.htm https://www.sciencedaily.com/releases/2025/04/250423185925.htm Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients. Wed, 23 Apr 2025 18:59:25 EDT https://www.sciencedaily.com/releases/2025/04/250423185925.htm https://www.sciencedaily.com/releases/2025/04/250422131528.htm The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study. The findings offer a new way to think about cancer beyond gene mutations, based on the way that genes are connected and regulated in three-dimensional space. Tue, 22 Apr 2025 13:15:28 EDT https://www.sciencedaily.com/releases/2025/04/250422131528.htm https://www.sciencedaily.com/releases/2025/04/250421163229.htm An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators report. Mon, 21 Apr 2025 16:32:29 EDT https://www.sciencedaily.com/releases/2025/04/250421163229.htm https://www.sciencedaily.com/releases/2025/04/250421162931.htm Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests. Mon, 21 Apr 2025 16:29:31 EDT https://www.sciencedaily.com/releases/2025/04/250421162931.htm https://www.sciencedaily.com/releases/2025/04/250415183430.htm Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Tue, 15 Apr 2025 18:34:30 EDT https://www.sciencedaily.com/releases/2025/04/250415183430.htm https://www.sciencedaily.com/releases/2025/04/250410130742.htm Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Thu, 10 Apr 2025 13:07:42 EDT https://www.sciencedaily.com/releases/2025/04/250410130742.htm https://www.sciencedaily.com/releases/2025/04/250401131309.htm A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two techniques to identify and test a drug for a young patient's tumor in time to be used for their treatment. Their success in finding a new drug for the patient shows how the study of proteins, known as proteomics, can be a valuable complement to the established study of genes (genomics) in real-time cancer therapies. Tue, 01 Apr 2025 13:13:09 EDT https://www.sciencedaily.com/releases/2025/04/250401131309.htm https://www.sciencedaily.com/releases/2025/03/250313151759.htm A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug Administration to treat gastrointestinal stromal tumors with a PDGFRA exon 18 mutation as well advanced systemic mastocytosis and indolent systemic mastocytosis. Thu, 13 Mar 2025 15:17:59 EDT https://www.sciencedaily.com/releases/2025/03/250313151759.htm https://www.sciencedaily.com/releases/2025/03/250310164014.htm In a study comparing the glioma tumors of firefighters and non-fighters, researchers found a mutational signature tied to exposure to haloalkanes, which are used in flame retardants, fire extinguishers, and pesticides. Mon, 10 Mar 2025 16:40:14 EDT https://www.sciencedaily.com/releases/2025/03/250310164014.htm https://www.sciencedaily.com/releases/2025/02/250226163241.htm Scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones. Wed, 26 Feb 2025 16:32:41 EST https://www.sciencedaily.com/releases/2025/02/250226163241.htm https://www.sciencedaily.com/releases/2025/02/250226163234.htm New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common and aggressive type of primary brain cancer. The researchers describe four gene expression 'programs' -- sets of genes with coordinated activity -- that either suppress the immune system or make it more active. Defining and understanding what drives these programs could one day help researchers target them with new drugs to dial up or down specific parts of the immune system to improve patient response to immunotherapy. Wed, 26 Feb 2025 16:32:34 EST https://www.sciencedaily.com/releases/2025/02/250226163234.htm https://www.sciencedaily.com/releases/2025/02/250219111315.htm Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue. Wed, 19 Feb 2025 11:13:15 EST https://www.sciencedaily.com/releases/2025/02/250219111315.htm https://www.sciencedaily.com/releases/2025/02/250213144435.htm When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels ensure nutritional and respiratory biological exchanges. Lymphangiogenesis, i.e. the development of lymphatic vessels, is generally associated with a poor prognosis, as it favours the spread of metastases to other organs. By studying the cells that make up the wall of lymphatic vessels, a team has made an unexpected discovery: an enzyme they express appears to play a key role in supporting immune cells, particularly when they are activated by anti-tumor treatments. These results could pave the way for improving the effectiveness of immunotherapies. Thu, 13 Feb 2025 14:44:35 EST https://www.sciencedaily.com/releases/2025/02/250213144435.htm https://www.sciencedaily.com/releases/2025/02/250210133016.htm Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Mon, 10 Feb 2025 13:30:16 EST https://www.sciencedaily.com/releases/2025/02/250210133016.htm https://www.sciencedaily.com/releases/2025/02/250207133429.htm A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research. Fri, 07 Feb 2025 13:34:29 EST https://www.sciencedaily.com/releases/2025/02/250207133429.htm https://www.sciencedaily.com/releases/2025/02/250207122748.htm Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why these tumors don't respond to existing immunotherapies. Fri, 07 Feb 2025 12:27:48 EST https://www.sciencedaily.com/releases/2025/02/250207122748.htm https://www.sciencedaily.com/releases/2025/02/250206113126.htm A new study of breast cancer survivors has found this psychosocial challenge impacts almost every important domain of their lives -- the emotional, behavioral, cognitive, relational and professional. A larger number of domains was affected, and they were affected more frequently in those with greater fear of recurrence. The majority of study participants indicated that they sought senses of purpose, belonging, control and connection with others. Thu, 06 Feb 2025 11:31:26 EST https://www.sciencedaily.com/releases/2025/02/250206113126.htm https://www.sciencedaily.com/releases/2025/02/250204132413.htm Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was shown to target a specific subset of tumor cells responsible for recurrence and therapy resistance in pediatric brain cancer. The findings could lead to more effective, less toxic treatments, improving survival and quality of life for young patients. Tue, 04 Feb 2025 13:24:13 EST https://www.sciencedaily.com/releases/2025/02/250204132413.htm https://www.sciencedaily.com/releases/2025/02/250204132410.htm A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it. Tue, 04 Feb 2025 13:24:10 EST https://www.sciencedaily.com/releases/2025/02/250204132410.htm https://www.sciencedaily.com/releases/2025/01/250124151243.htm Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation. Fri, 24 Jan 2025 15:12:43 EST https://www.sciencedaily.com/releases/2025/01/250124151243.htm https://www.sciencedaily.com/releases/2025/01/250124151010.htm Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer. Fri, 24 Jan 2025 15:10:10 EST https://www.sciencedaily.com/releases/2025/01/250124151010.htm https://www.sciencedaily.com/releases/2025/01/250123110236.htm New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully form. Thu, 23 Jan 2025 11:02:36 EST https://www.sciencedaily.com/releases/2025/01/250123110236.htm https://www.sciencedaily.com/releases/2025/01/250108144420.htm A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer. Wed, 08 Jan 2025 14:44:20 EST https://www.sciencedaily.com/releases/2025/01/250108144420.htm https://www.sciencedaily.com/releases/2025/01/250108143350.htm Thanks to new high-frequency electrical stimulation that blocks spasticity, two paralyzed patients suffering from muscle stiffness after spinal cord injury benefit from rehabilitation protocols for walking again. Wed, 08 Jan 2025 14:33:50 EST https://www.sciencedaily.com/releases/2025/01/250108143350.htm https://www.sciencedaily.com/releases/2025/01/250103124918.htm A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. Fri, 03 Jan 2025 12:49:18 EST https://www.sciencedaily.com/releases/2025/01/250103124918.htm https://www.sciencedaily.com/releases/2024/12/241217131240.htm Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer. Tue, 17 Dec 2024 13:12:40 EST https://www.sciencedaily.com/releases/2024/12/241217131240.htm https://www.sciencedaily.com/releases/2024/12/241216165133.htm Medical researchers have announced the results of an innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma while maintaining quality of life. Glioblastoma is the most lethal type of primary brain cancer due to its aggressive nature and its treatment-resistant characteristics. It is the most common form of primary brain cancer. Mon, 16 Dec 2024 16:51:33 EST https://www.sciencedaily.com/releases/2024/12/241216165133.htm https://www.sciencedaily.com/releases/2024/12/241206002144.htm An MRI-based imaging technique predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models. Fri, 06 Dec 2024 00:21:44 EST https://www.sciencedaily.com/releases/2024/12/241206002144.htm https://www.sciencedaily.com/releases/2024/12/241204114028.htm Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, empowering patients to regain confidence and move forward with their lives. Wed, 04 Dec 2024 11:40:28 EST https://www.sciencedaily.com/releases/2024/12/241204114028.htm https://www.sciencedaily.com/releases/2024/12/241203194354.htm Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause. Tue, 03 Dec 2024 19:43:54 EST https://www.sciencedaily.com/releases/2024/12/241203194354.htm https://www.sciencedaily.com/releases/2024/12/241203154041.htm Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one but two different brain cancer receptors. Tue, 03 Dec 2024 15:40:41 EST https://www.sciencedaily.com/releases/2024/12/241203154041.htm https://www.sciencedaily.com/releases/2024/11/241126135741.htm Cancer cells on the surface are thought to have natural advantages compared to cells deep within, which is why scientists have hypothesized tumors grow more in their periphery than in the core. A recent study found the opposite is true: tumors grow throughout their mass. The findings challenge the idea that a tumor is a 'two-speed' entity. Tue, 26 Nov 2024 13:57:41 EST https://www.sciencedaily.com/releases/2024/11/241126135741.htm https://www.sciencedaily.com/releases/2024/11/241125125654.htm A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. Mon, 25 Nov 2024 12:56:54 EST https://www.sciencedaily.com/releases/2024/11/241125125654.htm https://www.sciencedaily.com/releases/2024/11/241114125646.htm Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition. Thu, 14 Nov 2024 12:56:46 EST https://www.sciencedaily.com/releases/2024/11/241114125646.htm https://www.sciencedaily.com/releases/2024/11/241114125434.htm Researchers have uncovered a surprising new role for netrin1, a crucial protein in neural development, as a regulator that limits bone morphogenetic protein signaling in the developing spinal cord. Thu, 14 Nov 2024 12:54:34 EST https://www.sciencedaily.com/releases/2024/11/241114125434.htm https://www.sciencedaily.com/releases/2024/11/241113123219.htm Researchers have developed an AI powered model that -- in 10 seconds -- can determine during surgery if any part of a cancerous brain tumor that could be removed remains.The technology, called FastGlioma, outperformed conventional methods for identifying what remains of a tumor by a wide margin. Researchers say it has the potential to change the field of neurosurgery by immediately improving comprehensive management of patients with diffuse gliomas. Wed, 13 Nov 2024 12:32:19 EST https://www.sciencedaily.com/releases/2024/11/241113123219.htm https://www.sciencedaily.com/releases/2024/11/241112191059.htm A recent study correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aerodigestive cancer. Tue, 12 Nov 2024 19:10:59 EST https://www.sciencedaily.com/releases/2024/11/241112191059.htm https://www.sciencedaily.com/releases/2024/11/241107160742.htm Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack. Thu, 07 Nov 2024 16:07:42 EST https://www.sciencedaily.com/releases/2024/11/241107160742.htm https://www.sciencedaily.com/releases/2024/11/241104142208.htm Researchers have uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. These targets were identified through a screen for genetic vulnerabilities in patient-derived cancer stem cells that represent the variability found in tumors. Mon, 04 Nov 2024 14:22:08 EST https://www.sciencedaily.com/releases/2024/11/241104142208.htm https://www.sciencedaily.com/releases/2024/10/241022133250.htm Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Tue, 22 Oct 2024 13:32:50 EDT https://www.sciencedaily.com/releases/2024/10/241022133250.htm https://www.sciencedaily.com/releases/2024/10/241021170352.htm A team has re-engineered immune cells with a light-activated switch that modulates protein function and cellular behavior. When exposed to blue light, the cells change shape, infiltrating solid tumors grown in the lab and killing them. Mon, 21 Oct 2024 17:03:52 EDT https://www.sciencedaily.com/releases/2024/10/241021170352.htm